LINC00299

Across TCGA pan-cancer cohorts, LINC00299 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of LINC00299’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC00299 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC00299 is over-expressed in tumor.

KIRC, STAD, and KIRP are the cancer types where LINC00299 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00299 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	All	+0.276	<.001	11	view →
STAD	All	II,III,IV	+0.240	<.001	8	view →
KIRP	Male	All	+0.117	.004	8	view →
COAD	All	All	+0.114	<.001	6	view →
HNSC	All	All	+0.042	.010	5	view →
BRCA	All	All	+0.086	.002	4	view →
READ	All	All	+0.235	.002	2	view →
LIHC	All	All	+0.140	.003	2	view →
CHOL	All	All	+0.443	.034	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

LINC00299–KIRC

Open the KIRC breakdown →